Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.10512259 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.10512259 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.73685613 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.32835419 |
5 | COPI coating of Golgi vesicle (GO:0048205) | 3.88584175 |
6 | Golgi transport vesicle coating (GO:0048200) | 3.88584175 |
7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.86743226 |
8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.81339427 |
9 | positive regulation of histone deacetylation (GO:0031065) | 3.57674281 |
10 | hemidesmosome assembly (GO:0031581) | 3.54464409 |
11 | regulation of gamma-delta T cell activation (GO:0046643) | 3.49753602 |
12 | low-density lipoprotein particle clearance (GO:0034383) | 3.43150432 |
13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.39989198 |
14 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.39278482 |
15 | cell-substrate adherens junction assembly (GO:0007045) | 3.36370296 |
16 | focal adhesion assembly (GO:0048041) | 3.36370296 |
17 | apoptotic cell clearance (GO:0043277) | 3.31169486 |
18 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.26868952 |
19 | adherens junction assembly (GO:0034333) | 3.25253025 |
20 | regulation of cholesterol storage (GO:0010885) | 3.20883891 |
21 | stress fiber assembly (GO:0043149) | 3.15599562 |
22 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09755338 |
23 | response to peptidoglycan (GO:0032494) | 3.09317780 |
24 | positive thymic T cell selection (GO:0045059) | 3.05667467 |
25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.02956464 |
26 | modulation by symbiont of host defense response (GO:0052031) | 3.02956464 |
27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.02956464 |
28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.02956464 |
29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.02956464 |
30 | modulation by symbiont of host immune response (GO:0052553) | 3.02956464 |
31 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.01753609 |
32 | regulation of early endosome to late endosome transport (GO:2000641) | 2.99989985 |
33 | skin morphogenesis (GO:0043589) | 2.99464848 |
34 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.95422021 |
35 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.95154330 |
36 | response to laminar fluid shear stress (GO:0034616) | 2.94656764 |
37 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.88893722 |
38 | positive regulation of protein deacetylation (GO:0090312) | 2.88620517 |
39 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.88413412 |
40 | hypotonic response (GO:0006971) | 2.85649311 |
41 | positive regulation of interferon-alpha production (GO:0032727) | 2.85091951 |
42 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.81680245 |
43 | activation of Rac GTPase activity (GO:0032863) | 2.80613214 |
44 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.80232264 |
45 | positive regulation of receptor recycling (GO:0001921) | 2.79916682 |
46 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.75664552 |
47 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.75411175 |
48 | growth hormone receptor signaling pathway (GO:0060396) | 2.75122201 |
49 | negative regulation of necroptotic process (GO:0060546) | 2.74102892 |
50 | membrane raft organization (GO:0031579) | 2.73895348 |
51 | embryonic process involved in female pregnancy (GO:0060136) | 2.73330869 |
52 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.73189530 |
53 | positive regulation of B cell differentiation (GO:0045579) | 2.72757418 |
54 | mannose metabolic process (GO:0006013) | 2.72592709 |
55 | plasma membrane repair (GO:0001778) | 2.71329458 |
56 | basement membrane organization (GO:0071711) | 2.71015053 |
57 | regulation of interferon-alpha production (GO:0032647) | 2.69838894 |
58 | cell adhesion mediated by integrin (GO:0033627) | 2.69597414 |
59 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.66649391 |
60 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.65730874 |
61 | regulation of necroptotic process (GO:0060544) | 2.64617817 |
62 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.63137733 |
63 | protein localization to endosome (GO:0036010) | 2.63081872 |
64 | macrophage activation involved in immune response (GO:0002281) | 2.62746654 |
65 | natural killer cell differentiation (GO:0001779) | 2.61229344 |
66 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.60536001 |
67 | negative regulation of interleukin-12 production (GO:0032695) | 2.59199413 |
68 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.57438222 |
69 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.57340259 |
70 | positive regulation of p38MAPK cascade (GO:1900745) | 2.56790705 |
71 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.55683174 |
72 | negative regulation of fatty acid transport (GO:2000192) | 2.55157543 |
73 | pinocytosis (GO:0006907) | 2.54321417 |
74 | NADPH regeneration (GO:0006740) | 2.53611260 |
75 | regulation of integrin activation (GO:0033623) | 2.49297062 |
76 | positive regulation of lamellipodium assembly (GO:0010592) | 2.48503159 |
77 | membrane protein ectodomain proteolysis (GO:0006509) | 2.47018727 |
78 | morphogenesis of an endothelium (GO:0003159) | 2.46484487 |
79 | endothelial tube morphogenesis (GO:0061154) | 2.46484487 |
80 | negative regulation of cell killing (GO:0031342) | 2.46138130 |
81 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.46138130 |
82 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.46130274 |
83 | cellular response to growth hormone stimulus (GO:0071378) | 2.45838378 |
84 | desmosome organization (GO:0002934) | 2.43153847 |
85 | hepatocyte apoptotic process (GO:0097284) | 2.42719955 |
86 | modulation by symbiont of host cellular process (GO:0044068) | 2.42420548 |
87 | glucose catabolic process (GO:0006007) | 2.42267504 |
88 | pentose-phosphate shunt (GO:0006098) | 2.42259754 |
89 | neutrophil activation involved in immune response (GO:0002283) | 2.42212251 |
90 | barbed-end actin filament capping (GO:0051016) | 2.42043953 |
91 | NIK/NF-kappaB signaling (GO:0038061) | 2.41734232 |
92 | thymic T cell selection (GO:0045061) | 2.41693539 |
93 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.41216838 |
94 | immunoglobulin mediated immune response (GO:0016064) | 2.39754650 |
95 | cell-substrate junction assembly (GO:0007044) | 2.39549950 |
96 | regulation of leukocyte degranulation (GO:0043300) | 2.39115354 |
97 | positive regulation of lipid storage (GO:0010884) | 2.38865169 |
98 | regulation of response to interferon-gamma (GO:0060330) | 2.37829987 |
99 | response to muramyl dipeptide (GO:0032495) | 2.37171257 |
100 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.36738189 |
101 | protein retention in ER lumen (GO:0006621) | 2.36300154 |
102 | leukocyte cell-cell adhesion (GO:0007159) | 2.35792826 |
103 | cortical actin cytoskeleton organization (GO:0030866) | 2.35088495 |
104 | response to interferon-alpha (GO:0035455) | 2.34332690 |
105 | negative regulation of cell size (GO:0045792) | 2.34212045 |
106 | negative regulation of phagocytosis (GO:0050765) | 2.34017714 |
107 | positive regulation of lamellipodium organization (GO:1902745) | 2.33384728 |
108 | regulation of necrotic cell death (GO:0010939) | 2.32475415 |
109 | establishment of endothelial barrier (GO:0061028) | 2.31995996 |
110 | epithelial cell-cell adhesion (GO:0090136) | 2.31926650 |
111 | regulation of macrophage cytokine production (GO:0010935) | 2.30047525 |
112 | regulation of B cell differentiation (GO:0045577) | 2.29506532 |
113 | cellular response to interferon-alpha (GO:0035457) | 2.29151216 |
114 | sarcomere organization (GO:0045214) | 2.28753740 |
115 | negative regulation of granulocyte differentiation (GO:0030853) | 2.28542085 |
116 | regulation of extracellular matrix disassembly (GO:0010715) | 2.26374932 |
117 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.26301527 |
118 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.26244332 |
119 | negative regulation of stress fiber assembly (GO:0051497) | 2.26109250 |
120 | endodermal cell differentiation (GO:0035987) | 2.25767957 |
121 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.25407906 |
122 | germinal center formation (GO:0002467) | 2.25366973 |
123 | response to type I interferon (GO:0034340) | 2.25114032 |
124 | positive regulation of myotube differentiation (GO:0010831) | 2.24013827 |
125 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.23349836 |
126 | maternal placenta development (GO:0001893) | 2.23089619 |
127 | platelet aggregation (GO:0070527) | 2.23009780 |
128 | leukocyte aggregation (GO:0070486) | 2.22134690 |
129 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.21637519 |
130 | response to fluid shear stress (GO:0034405) | 2.21290864 |
131 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.21174077 |
132 | response to host (GO:0075136) | 2.20758907 |
133 | response to host defenses (GO:0052200) | 2.20758907 |
134 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.20758907 |
135 | regulation of defense response to virus by virus (GO:0050690) | 2.20434468 |
136 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.20396170 |
137 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.20194998 |
138 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.20146983 |
139 | apoptotic process involved in morphogenesis (GO:0060561) | 2.19546524 |
140 | detection of other organism (GO:0098543) | 2.19471694 |
141 | tricarboxylic acid metabolic process (GO:0072350) | 2.19323439 |
142 | regulation of tight junction assembly (GO:2000810) | 2.18927649 |
143 | tolerance induction (GO:0002507) | 2.18641250 |
144 | germ cell migration (GO:0008354) | 2.18625755 |
145 | B cell receptor signaling pathway (GO:0050853) | 2.17802974 |
146 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.17782215 |
147 | valine metabolic process (GO:0006573) | 2.17763925 |
148 | negative regulation of viral release from host cell (GO:1902187) | 2.16856648 |
149 | glycosphingolipid catabolic process (GO:0046479) | 2.16535187 |
150 | glucose 6-phosphate metabolic process (GO:0051156) | 2.15958642 |
151 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.15364116 |
152 | positive regulation of nuclease activity (GO:0032075) | 2.15167326 |
153 | hyaluronan catabolic process (GO:0030214) | 2.15148929 |
154 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.14666145 |
155 | regulation of superoxide anion generation (GO:0032928) | 2.13710241 |
156 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.12519231 |
157 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.12260110 |
158 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.11550615 |
159 | cortical cytoskeleton organization (GO:0030865) | 2.11059120 |
160 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.09838836 |
161 | positive regulation of extracellular matrix organization (GO:1903055) | 2.09829770 |
162 | response to progesterone (GO:0032570) | 2.09577672 |
163 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.09285914 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.52313897 |
2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.37092138 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.06737729 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.84879379 |
5 | MYC_22102868_ChIP-Seq_BL_Human | 2.79275964 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.78950238 |
7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.45591044 |
8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.44608334 |
9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.44288391 |
10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.34974933 |
11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.28596440 |
12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.24873172 |
13 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.19821050 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19124488 |
15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.17786004 |
16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.14287226 |
17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.12056405 |
18 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.09298896 |
19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08650288 |
20 | MAF_26560356_Chip-Seq_TH1_Human | 2.06905233 |
21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.03578900 |
22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.00194960 |
23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.93518408 |
24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.91718898 |
25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.90946473 |
26 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.89758235 |
27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.87959458 |
28 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.81265883 |
29 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79953721 |
30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78222833 |
31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.75979213 |
32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.73667175 |
33 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.72061008 |
34 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.70142928 |
35 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.65894112 |
36 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.65244242 |
37 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64732843 |
38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.63441803 |
39 | MYB_26560356_Chip-Seq_TH2_Human | 1.61008274 |
40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60400699 |
41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60236268 |
42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59783816 |
43 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.59440768 |
44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57909172 |
45 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.57087633 |
46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56194172 |
47 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.55599087 |
48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.53479902 |
49 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.50547690 |
50 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.50384855 |
51 | MYB_26560356_Chip-Seq_TH1_Human | 1.47770549 |
52 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.47516784 |
53 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.46862396 |
54 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.46579112 |
55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45606425 |
56 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.45243185 |
57 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.45214395 |
58 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.44457660 |
59 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.39221919 |
60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37491240 |
61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.37334974 |
62 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.37140322 |
63 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.36963173 |
64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34670946 |
65 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.32726567 |
66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31762369 |
67 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.31027490 |
68 | KDM2B_26808549_Chip-Seq_K562_Human | 1.30043878 |
69 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.29256424 |
70 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29248768 |
71 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.27604889 |
72 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.27551563 |
73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27179344 |
74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26895024 |
75 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26487946 |
76 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.26293848 |
77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26278440 |
78 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.24924557 |
79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24365507 |
80 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23424268 |
81 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20416546 |
82 | MAF_26560356_Chip-Seq_TH2_Human | 1.19537325 |
83 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18964808 |
84 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18177591 |
85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18060794 |
86 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.17709874 |
87 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.16650040 |
88 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.16650040 |
89 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.16524278 |
90 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.16336750 |
91 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.15830948 |
92 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.15825036 |
93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14303032 |
94 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.14040321 |
95 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.13986049 |
96 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13965868 |
97 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13401854 |
98 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.12941082 |
99 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.12702898 |
100 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11645074 |
101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11375727 |
102 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09120148 |
103 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.08224789 |
104 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06792412 |
105 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06663505 |
106 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.05788485 |
107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05343237 |
108 | * P68_20966046_ChIP-Seq_HELA_Human | 1.05184456 |
109 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.05031868 |
110 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04417173 |
111 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04359841 |
112 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03300702 |
113 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03021713 |
114 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02927453 |
115 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.02138762 |
116 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02128656 |
117 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02111309 |
118 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.01864849 |
119 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.01864849 |
120 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01748035 |
121 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.01628412 |
122 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00912838 |
123 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00749200 |
124 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.00229747 |
125 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99951555 |
126 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99350783 |
127 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.99268497 |
128 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.99229092 |
129 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99006940 |
130 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.98683229 |
131 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98365803 |
132 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.98323568 |
133 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.97714014 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003705_abnormal_hypodermis_morpholog | 3.20169848 |
2 | MP0005451_abnormal_body_composition | 3.11653057 |
3 | MP0003303_peritoneal_inflammation | 2.63496666 |
4 | MP0003300_gastrointestinal_ulcer | 2.63342676 |
5 | MP0008438_abnormal_cutaneous_collagen | 2.48607156 |
6 | MP0003566_abnormal_cell_adhesion | 2.32959644 |
7 | MP0010352_gastrointestinal_tract_polyps | 2.21301168 |
8 | MP0008260_abnormal_autophagy | 2.19966180 |
9 | MP0001835_abnormal_antigen_presentation | 2.17618782 |
10 | MP0003436_decreased_susceptibility_to | 2.15422956 |
11 | MP0000685_abnormal_immune_system | 2.07942763 |
12 | MP0005058_abnormal_lysosome_morphology | 1.96004289 |
13 | MP0004233_abnormal_muscle_weight | 1.88930802 |
14 | MP0009840_abnormal_foam_cell | 1.85741990 |
15 | MP0004510_myositis | 1.77478717 |
16 | MP0009278_abnormal_bone_marrow | 1.73748042 |
17 | MP0003279_aneurysm | 1.69895359 |
18 | MP0001790_abnormal_immune_system | 1.69759864 |
19 | MP0005387_immune_system_phenotype | 1.69759864 |
20 | MP0004084_abnormal_cardiac_muscle | 1.69381854 |
21 | MP0005076_abnormal_cell_differentiation | 1.66290135 |
22 | MP0004947_skin_inflammation | 1.64351666 |
23 | MP0002166_altered_tumor_susceptibility | 1.63825171 |
24 | MP0002877_abnormal_melanocyte_morpholog | 1.61379462 |
25 | MP0001800_abnormal_humoral_immune | 1.61192349 |
26 | MP0005275_abnormal_skin_tensile | 1.59569600 |
27 | MP0004130_abnormal_muscle_cell | 1.57600382 |
28 | MP0002452_abnormal_antigen_presenting | 1.55423975 |
29 | MP0005464_abnormal_platelet_physiology | 1.55360290 |
30 | MP0002419_abnormal_innate_immunity | 1.55097115 |
31 | MP0006054_spinal_hemorrhage | 1.54263031 |
32 | MP0004272_abnormal_basement_membrane | 1.53047541 |
33 | MP0001958_emphysema | 1.51948985 |
34 | MP0009785_altered_susceptibility_to | 1.50385426 |
35 | MP0004858_abnormal_nervous_system | 1.47334716 |
36 | MP0005025_abnormal_response_to | 1.47290984 |
37 | MP0005000_abnormal_immune_tolerance | 1.46599194 |
38 | * MP0005023_abnormal_wound_healing | 1.45774961 |
39 | MP0004808_abnormal_hematopoietic_stem | 1.43377305 |
40 | MP0002796_impaired_skin_barrier | 1.43253163 |
41 | MP0003191_abnormal_cellular_cholesterol | 1.41755130 |
42 | MP0010155_abnormal_intestine_physiology | 1.40814191 |
43 | MP0003091_abnormal_cell_migration | 1.37883987 |
44 | MP0004185_abnormal_adipocyte_glucose | 1.36605181 |
45 | MP0001533_abnormal_skeleton_physiology | 1.35703199 |
46 | MP0001819_abnormal_immune_cell | 1.33869434 |
47 | MP0002420_abnormal_adaptive_immunity | 1.33841365 |
48 | MP0002723_abnormal_immune_serum | 1.33783223 |
49 | MP0003950_abnormal_plasma_membrane | 1.32785479 |
50 | MP0001873_stomach_inflammation | 1.32463080 |
51 | MP0000343_altered_response_to | 1.32143604 |
52 | MP0000747_muscle_weakness | 1.28601102 |
53 | MP0006082_CNS_inflammation | 1.27841905 |
54 | MP0005257_abnormal_intraocular_pressure | 1.26835156 |
55 | MP0003045_fibrosis | 1.26213807 |
56 | MP0000759_abnormal_skeletal_muscle | 1.26147233 |
57 | MP0005671_abnormal_response_to | 1.25878309 |
58 | MP0005409_darkened_coat_color | 1.25417026 |
59 | MP0002405_respiratory_system_inflammati | 1.24918215 |
60 | MP0002396_abnormal_hematopoietic_system | 1.24873659 |
61 | MP0000733_abnormal_muscle_development | 1.24151352 |
62 | MP0000750_abnormal_muscle_regeneration | 1.24009956 |
63 | MP0009333_abnormal_splenocyte_physiolog | 1.22918681 |
64 | MP0005397_hematopoietic_system_phenotyp | 1.22726393 |
65 | MP0001545_abnormal_hematopoietic_system | 1.22726393 |
66 | MP0002398_abnormal_bone_marrow | 1.22090274 |
67 | MP0003172_abnormal_lysosome_physiology | 1.21787091 |
68 | MP0010630_abnormal_cardiac_muscle | 1.21318835 |
69 | MP0005666_abnormal_adipose_tissue | 1.20343971 |
70 | MP0004087_abnormal_muscle_fiber | 1.19762341 |
71 | MP0005670_abnormal_white_adipose | 1.17778055 |
72 | MP0003828_pulmonary_edema | 1.16332045 |
73 | MP0010307_abnormal_tumor_latency | 1.14278207 |
74 | MP0002006_tumorigenesis | 1.14054021 |
75 | MP0000003_abnormal_adipose_tissue | 1.13604996 |
76 | MP0003448_altered_tumor_morphology | 1.13140522 |
77 | MP0001845_abnormal_inflammatory_respons | 1.13052502 |
78 | MP0000858_altered_metastatic_potential | 1.12433134 |
79 | MP0003763_abnormal_thymus_physiology | 1.11804505 |
80 | MP0000716_abnormal_immune_system | 1.11799007 |
81 | MP0003724_increased_susceptibility_to | 1.11252495 |
82 | MP0005501_abnormal_skin_physiology | 1.09657779 |
83 | MP0002148_abnormal_hypersensitivity_rea | 1.09599428 |
84 | MP0001853_heart_inflammation | 1.07424613 |
85 | MP0000767_abnormal_smooth_muscle | 1.07041869 |
86 | MP0010234_abnormal_vibrissa_follicle | 1.05992979 |
87 | MP0002722_abnormal_immune_system | 1.04657520 |
88 | MP0000689_abnormal_spleen_morphology | 1.04652017 |
89 | MP0002837_dystrophic_cardiac_calcinosis | 1.03576810 |
90 | MP0002933_joint_inflammation | 1.02715416 |
91 | MP0002332_abnormal_exercise_endurance | 1.02038731 |
92 | MP0004264_abnormal_extraembryonic_tissu | 1.01721924 |
93 | MP0002429_abnormal_blood_cell | 0.99625896 |
94 | MP0005375_adipose_tissue_phenotype | 0.99530758 |
95 | MP0003075_altered_response_to | 0.99177489 |
96 | MP0000751_myopathy | 0.98743768 |
97 | MP0002254_reproductive_system_inflammat | 0.98676297 |
98 | MP0005623_abnormal_meninges_morphology | 0.97911662 |
99 | MP0004036_abnormal_muscle_relaxation | 0.96171512 |
100 | MP0001216_abnormal_epidermal_layer | 0.95869858 |
101 | MP0005330_cardiomyopathy | 0.95528840 |
102 | MP0001849_ear_inflammation | 0.94530848 |
103 | MP0000749_muscle_degeneration | 0.92976972 |
104 | MP0005621_abnormal_cell_physiology | 0.92854199 |
105 | MP0000465_gastrointestinal_hemorrhage | 0.92773427 |
106 | MP0002269_muscular_atrophy | 0.91958773 |
107 | MP0008961_abnormal_basal_metabolism | 0.91879433 |
108 | MP0001348_abnormal_lacrimal_gland | 0.91665417 |
109 | MP0005165_increased_susceptibility_to | 0.91031638 |
110 | MP0008469_abnormal_protein_level | 0.90218564 |
111 | MP0002998_abnormal_bone_remodeling | 0.90109038 |
112 | MP0000249_abnormal_blood_vessel | 0.89797221 |
113 | MP0001851_eye_inflammation | 0.86802074 |
114 | MP0001915_intracranial_hemorrhage | 0.86605414 |
115 | MP0000490_abnormal_crypts_of | 0.86071471 |
116 | MP0001544_abnormal_cardiovascular_syste | 0.85935541 |
117 | MP0005385_cardiovascular_system_phenoty | 0.85935541 |
118 | MP0003866_abnormal_defecation | 0.85680604 |
119 | MP0003329_amyloid_beta_deposits | 0.85274950 |
120 | MP0002060_abnormal_skin_morphology | 0.84718518 |
121 | MP0000609_abnormal_liver_physiology | 0.84429580 |
122 | MP0008775_abnormal_heart_ventricle | 0.83423970 |
123 | MP0006138_congestive_heart_failure | 0.83017990 |
124 | MP0000678_abnormal_parathyroid_gland | 0.82965386 |
125 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82607902 |
126 | MP0003453_abnormal_keratinocyte_physiol | 0.82569594 |
127 | MP0001879_abnormal_lymphatic_vessel | 0.82436018 |
128 | MP0002896_abnormal_bone_mineralization | 0.81432267 |
129 | MP0010368_abnormal_lymphatic_system | 0.81241640 |
130 | MP0002128_abnormal_blood_circulation | 0.81043258 |
131 | MP0000013_abnormal_adipose_tissue | 0.79865362 |
132 | MP0003656_abnormal_erythrocyte_physiolo | 0.77339718 |
133 | MP0001243_abnormal_dermal_layer | 0.75943517 |
134 | MP0009931_abnormal_skin_appearance | 0.73605980 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Distal lower limb amyotrophy (HP:0008944) | 3.62664557 |
2 | Cerebral aneurysm (HP:0004944) | 3.58543579 |
3 | Distal lower limb muscle weakness (HP:0009053) | 3.58351512 |
4 | Aortic aneurysm (HP:0004942) | 3.38923962 |
5 | Eczematoid dermatitis (HP:0000976) | 3.32534147 |
6 | Increased connective tissue (HP:0009025) | 3.22963299 |
7 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.16269500 |
8 | Protrusio acetabuli (HP:0003179) | 3.13129041 |
9 | Exercise-induced myalgia (HP:0003738) | 3.03681355 |
10 | Nemaline bodies (HP:0003798) | 2.94342182 |
11 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.92698021 |
12 | Broad face (HP:0000283) | 2.90146912 |
13 | Muscle fiber inclusion bodies (HP:0100299) | 2.89388961 |
14 | Recurrent abscess formation (HP:0002722) | 2.77350539 |
15 | Abnormality of the nasal mucosa (HP:0000433) | 2.71994316 |
16 | Increased variability in muscle fiber diameter (HP:0003557) | 2.71395238 |
17 | Interstitial pulmonary disease (HP:0006530) | 2.65021763 |
18 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.62571663 |
19 | Osteolytic defects of the hand bones (HP:0009699) | 2.62571663 |
20 | Increased density of long bones (HP:0006392) | 2.62357027 |
21 | Hematochezia (HP:0002573) | 2.57452871 |
22 | Spinal rigidity (HP:0003306) | 2.55579072 |
23 | Nasal polyposis (HP:0100582) | 2.53563211 |
24 | Cellulitis (HP:0100658) | 2.51798698 |
25 | Aneurysm (HP:0002617) | 2.50996765 |
26 | Asymmetric septal hypertrophy (HP:0001670) | 2.50306347 |
27 | Achilles tendon contracture (HP:0001771) | 2.48267889 |
28 | Lower limb amyotrophy (HP:0007210) | 2.46486215 |
29 | Aortic dissection (HP:0002647) | 2.46408301 |
30 | Recurrent bacterial skin infections (HP:0005406) | 2.46358239 |
31 | Right ventricular cardiomyopathy (HP:0011663) | 2.45523796 |
32 | Ankle contracture (HP:0006466) | 2.45423131 |
33 | Autoimmune thrombocytopenia (HP:0001973) | 2.45249830 |
34 | Cervical subluxation (HP:0003308) | 2.44420952 |
35 | Peritonitis (HP:0002586) | 2.38531232 |
36 | Frequent falls (HP:0002359) | 2.38466601 |
37 | Premature rupture of membranes (HP:0001788) | 2.38057200 |
38 | Broad metatarsal (HP:0001783) | 2.37148171 |
39 | Myocardial infarction (HP:0001658) | 2.36696035 |
40 | Increased cerebral lipofuscin (HP:0011813) | 2.36266279 |
41 | Short nail (HP:0001799) | 2.34282662 |
42 | Myopathic facies (HP:0002058) | 2.33535270 |
43 | Hyporeflexia of lower limbs (HP:0002600) | 2.33342530 |
44 | Atrophic scars (HP:0001075) | 2.30702015 |
45 | Spontaneous hematomas (HP:0007420) | 2.30347381 |
46 | Recurrent viral infections (HP:0004429) | 2.28246306 |
47 | Facial diplegia (HP:0001349) | 2.27391223 |
48 | Mitral valve prolapse (HP:0001634) | 2.27075372 |
49 | Type 1 muscle fiber predominance (HP:0003803) | 2.25825656 |
50 | Recurrent fungal infections (HP:0002841) | 2.25585443 |
51 | Abnormality of the Achilles tendon (HP:0005109) | 2.21582466 |
52 | Dilatation of the ascending aorta (HP:0005111) | 2.20868837 |
53 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.20784365 |
54 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.20784365 |
55 | Abnormality of glycolipid metabolism (HP:0010969) | 2.20784365 |
56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.20552786 |
57 | Fragile skin (HP:0001030) | 2.19593741 |
58 | Distal upper limb amyotrophy (HP:0007149) | 2.18347714 |
59 | Upper limb amyotrophy (HP:0009129) | 2.18347714 |
60 | Difficulty climbing stairs (HP:0003551) | 2.16961653 |
61 | Polycythemia (HP:0001901) | 2.15921374 |
62 | Pustule (HP:0200039) | 2.15448314 |
63 | Difficulty running (HP:0009046) | 2.15108939 |
64 | Colitis (HP:0002583) | 2.14371040 |
65 | Ventricular tachycardia (HP:0004756) | 2.13695723 |
66 | Myositis (HP:0100614) | 2.11589761 |
67 | Ulnar bowing (HP:0003031) | 2.08371481 |
68 | Gastrointestinal inflammation (HP:0004386) | 2.08146370 |
69 | Shallow orbits (HP:0000586) | 2.07379096 |
70 | Inflammation of the large intestine (HP:0002037) | 2.06208387 |
71 | Chronic otitis media (HP:0000389) | 2.05131919 |
72 | Muscle fiber splitting (HP:0003555) | 2.03674458 |
73 | Abnormal platelet volume (HP:0011876) | 2.03081627 |
74 | Abnormality of macrophages (HP:0004311) | 2.02805583 |
75 | Hand muscle atrophy (HP:0009130) | 2.00686912 |
76 | Spondylolisthesis (HP:0003302) | 1.97007901 |
77 | Dysostosis multiplex (HP:0000943) | 1.96839808 |
78 | Striae distensae (HP:0001065) | 1.96472097 |
79 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.95957155 |
80 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.95746744 |
81 | Increased mean platelet volume (HP:0011877) | 1.94439247 |
82 | Ulnar deviation of the wrist (HP:0003049) | 1.93182005 |
83 | Emphysema (HP:0002097) | 1.90254177 |
84 | Vertebral compression fractures (HP:0002953) | 1.90179710 |
85 | Generalized amyotrophy (HP:0003700) | 1.89686463 |
86 | Thin bony cortex (HP:0002753) | 1.88788090 |
87 | Esophageal varix (HP:0002040) | 1.88724387 |
88 | Systemic lupus erythematosus (HP:0002725) | 1.87851804 |
89 | Axonal loss (HP:0003447) | 1.87726224 |
90 | Arterial tortuosity (HP:0005116) | 1.86406518 |
91 | Exercise-induced muscle cramps (HP:0003710) | 1.86171664 |
92 | Arterial thrombosis (HP:0004420) | 1.85332076 |
93 | Neck muscle weakness (HP:0000467) | 1.84153557 |
94 | Papilloma (HP:0012740) | 1.84035817 |
95 | Verrucae (HP:0200043) | 1.84035817 |
96 | Scapular winging (HP:0003691) | 1.83701630 |
97 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.82606493 |
98 | Vacuolated lymphocytes (HP:0001922) | 1.82416971 |
99 | Fatigue (HP:0012378) | 1.82319654 |
100 | Long toe (HP:0010511) | 1.82246018 |
101 | Myoglobinuria (HP:0002913) | 1.81821277 |
102 | Amyloidosis (HP:0011034) | 1.80095637 |
103 | Abnormality of the fingertips (HP:0001211) | 1.79611163 |
104 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.78915378 |
105 | Vascular tortuosity (HP:0004948) | 1.78752694 |
106 | Bulbar palsy (HP:0001283) | 1.77597465 |
107 | Radial bowing (HP:0002986) | 1.77269842 |
108 | Wormian bones (HP:0002645) | 1.77073262 |
109 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.76386535 |
110 | Mucopolysacchariduria (HP:0008155) | 1.76386535 |
111 | Round ear (HP:0100830) | 1.76309663 |
112 | Mitral regurgitation (HP:0001653) | 1.76301106 |
113 | Bicuspid aortic valve (HP:0001647) | 1.76290821 |
114 | Persistence of primary teeth (HP:0006335) | 1.76271624 |
115 | Gingivitis (HP:0000230) | 1.74862617 |
116 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.74320981 |
117 | Lipoatrophy (HP:0100578) | 1.74155388 |
118 | Trismus (HP:0000211) | 1.73755622 |
119 | Abnormal platelet function (HP:0011869) | 1.73604192 |
120 | Impaired platelet aggregation (HP:0003540) | 1.73604192 |
121 | Blue sclerae (HP:0000592) | 1.73396912 |
122 | Rhabdomyolysis (HP:0003201) | 1.73361209 |
123 | Periodontitis (HP:0000704) | 1.72208522 |
124 | Sudden death (HP:0001699) | 1.71287617 |
125 | Increased IgE level (HP:0003212) | 1.70364111 |
126 | Recurrent bronchitis (HP:0002837) | 1.69907481 |
127 | Natal tooth (HP:0000695) | 1.69520598 |
128 | Disproportionate tall stature (HP:0001519) | 1.69358259 |
129 | Cerebral inclusion bodies (HP:0100314) | 1.68352278 |
130 | Chest pain (HP:0100749) | 1.67841737 |
131 | EMG: myopathic abnormalities (HP:0003458) | 1.66856005 |
132 | Stridor (HP:0010307) | 1.66407642 |
133 | Loss of speech (HP:0002371) | 1.66357296 |
134 | Recurrent skin infections (HP:0001581) | 1.66312738 |
135 | Thrombocytosis (HP:0001894) | 1.66200440 |
136 | Bladder diverticulum (HP:0000015) | 1.65860611 |
137 | Nuclear cataract (HP:0100018) | 1.65804415 |
138 | Osteomyelitis (HP:0002754) | 1.65179865 |
139 | Flat acetabular roof (HP:0003180) | 1.64957087 |
140 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.63484605 |
141 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.63484605 |
142 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.63484605 |
143 | Back pain (HP:0003418) | 1.63381524 |
144 | Abnormality of oral frenula (HP:0000190) | 1.62658802 |
145 | Muscle stiffness (HP:0003552) | 1.62543396 |
146 | Easy fatigability (HP:0003388) | 1.61036484 |
147 | Thick nail (HP:0001805) | 1.60924653 |
148 | Long palpebral fissure (HP:0000637) | 1.60263887 |
149 | Spinal cord lesions (HP:0100561) | 1.58985898 |
150 | Syringomyelia (HP:0003396) | 1.58985898 |
151 | Slender build (HP:0001533) | 1.58958095 |
152 | Ragged-red muscle fibers (HP:0003200) | 1.58567627 |
153 | Elbow flexion contracture (HP:0002987) | 1.58176802 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 4.25810797 |
2 | TTN | 3.58059104 |
3 | PKN2 | 3.50858711 |
4 | ERN1 | 3.12926471 |
5 | MAP4K1 | 2.98891233 |
6 | SMG1 | 2.89898317 |
7 | PRPF4B | 2.83344879 |
8 | IRAK3 | 2.78675038 |
9 | EEF2K | 2.71407688 |
10 | MAP3K10 | 2.22988436 |
11 | ICK | 2.22455417 |
12 | STK10 | 2.13171726 |
13 | LRRK2 | 2.02084284 |
14 | TYK2 | 1.91874016 |
15 | PTK6 | 1.86716897 |
16 | JAK3 | 1.86314395 |
17 | TGFBR2 | 1.82970959 |
18 | MAP2K3 | 1.79937706 |
19 | RIPK1 | 1.79397010 |
20 | TBK1 | 1.77310770 |
21 | FGFR4 | 1.75606167 |
22 | EPHB1 | 1.67939250 |
23 | MAP3K13 | 1.64081398 |
24 | SIK1 | 1.63303479 |
25 | NME2 | 1.62540205 |
26 | JAK1 | 1.54685318 |
27 | ZAP70 | 1.45009233 |
28 | TESK1 | 1.43918291 |
29 | TAOK2 | 1.40394540 |
30 | FLT3 | 1.34784564 |
31 | PDGFRA | 1.31942178 |
32 | KIT | 1.31793011 |
33 | DMPK | 1.27117385 |
34 | CDK12 | 1.24309789 |
35 | CAMK1D | 1.21021815 |
36 | CSK | 1.19500401 |
37 | MOS | 1.18209839 |
38 | TESK2 | 1.12559134 |
39 | FGFR3 | 1.11725575 |
40 | NEK9 | 1.08856593 |
41 | MAP3K6 | 1.05805810 |
42 | CDC42BPA | 1.04255269 |
43 | ITK | 1.03870531 |
44 | MAP3K1 | 1.02911109 |
45 | CSF1R | 1.02685848 |
46 | BTK | 1.01908886 |
47 | RIPK4 | 1.01510018 |
48 | MET | 1.00633950 |
49 | HCK | 1.00523028 |
50 | TRPM7 | 1.00449357 |
51 | MAP3K7 | 1.00288006 |
52 | MAP3K14 | 0.99833467 |
53 | IRAK4 | 0.99074308 |
54 | BMX | 0.99069169 |
55 | PAK4 | 0.98771790 |
56 | GRK6 | 0.97764524 |
57 | RPS6KA4 | 0.96171596 |
58 | KSR2 | 0.94483072 |
59 | PRKD2 | 0.93922416 |
60 | ARAF | 0.93118333 |
61 | BLK | 0.92973921 |
62 | LMTK2 | 0.89269460 |
63 | EPHA3 | 0.88209684 |
64 | KDR | 0.88131838 |
65 | MAP3K3 | 0.87189906 |
66 | SCYL2 | 0.86006545 |
67 | TAOK3 | 0.85270649 |
68 | PRKG2 | 0.84871972 |
69 | JAK2 | 0.81902275 |
70 | SIK3 | 0.81518937 |
71 | LATS2 | 0.80723495 |
72 | CDK6 | 0.79662800 |
73 | MTOR | 0.79502330 |
74 | PIM1 | 0.77885037 |
75 | MARK2 | 0.75674258 |
76 | IKBKE | 0.75197270 |
77 | PDPK1 | 0.74813395 |
78 | PDGFRB | 0.74489773 |
79 | MARK3 | 0.73771130 |
80 | TAOK1 | 0.73766640 |
81 | CDK4 | 0.72628436 |
82 | TGFBR1 | 0.70961060 |
83 | IKBKB | 0.70839412 |
84 | CHUK | 0.67451470 |
85 | PAK2 | 0.67104564 |
86 | LIMK1 | 0.66564262 |
87 | ALK | 0.66281654 |
88 | PTK2 | 0.66121330 |
89 | MAP3K8 | 0.66080050 |
90 | MATK | 0.65744882 |
91 | CAMK1G | 0.65510596 |
92 | MAPKAPK3 | 0.65125797 |
93 | SYK | 0.64610618 |
94 | LCK | 0.64380114 |
95 | OBSCN | 0.64171572 |
96 | RPS6KB2 | 0.63650240 |
97 | RET | 0.63277186 |
98 | NEK2 | 0.63272252 |
99 | IRAK2 | 0.62357672 |
100 | STK4 | 0.62208953 |
101 | NTRK1 | 0.60920502 |
102 | ILK | 0.59061888 |
103 | FGR | 0.58496414 |
104 | STK38 | 0.58020330 |
105 | STK3 | 0.57927914 |
106 | DYRK1B | 0.57150259 |
107 | MYLK | 0.55951485 |
108 | MAP3K11 | 0.55422494 |
109 | PRKD1 | 0.55057097 |
110 | SIK2 | 0.54543347 |
111 | MAPK12 | 0.54125054 |
112 | PRKCH | 0.53563231 |
113 | EPHA2 | 0.53326881 |
114 | NEK1 | 0.52357109 |
115 | TXK | 0.51914377 |
116 | MAPK11 | 0.51582454 |
117 | TIE1 | 0.50382144 |
118 | DDR2 | 0.50208018 |
119 | PIM2 | 0.50054601 |
120 | MAPKAPK2 | 0.49044947 |
121 | PIK3CG | 0.46190384 |
122 | HIPK2 | 0.43712987 |
123 | RPS6KA6 | 0.42727499 |
124 | EGFR | 0.41887579 |
125 | TEC | 0.41433461 |
126 | MST1R | 0.41120252 |
127 | PRKAA2 | 0.41044196 |
128 | MAPK7 | 0.40490979 |
129 | ERBB4 | 0.40444812 |
130 | RPS6KL1 | 0.40029547 |
131 | RPS6KC1 | 0.40029547 |
132 | PDK1 | 0.38522735 |
133 | CDK9 | 0.36064136 |
134 | MAP2K2 | 0.35559022 |
135 | CDK7 | 0.35396589 |
136 | STK24 | 0.33752234 |
137 | RPS6KA2 | 0.33178629 |
138 | MELK | 0.32977080 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.24534081 |
2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.98813832 |
3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94271772 |
4 | Viral myocarditis_Homo sapiens_hsa05416 | 1.81405329 |
5 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.76192795 |
6 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.76052978 |
7 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75960390 |
8 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.72627858 |
9 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.69939049 |
10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67600490 |
11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.58197399 |
12 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.55201522 |
13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.55114574 |
14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.50485091 |
15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.50482431 |
16 | Measles_Homo sapiens_hsa05162 | 1.47681470 |
17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45495313 |
18 | Insulin resistance_Homo sapiens_hsa04931 | 1.41516600 |
19 | Focal adhesion_Homo sapiens_hsa04510 | 1.41351612 |
20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.40391763 |
21 | Apoptosis_Homo sapiens_hsa04210 | 1.37669057 |
22 | Shigellosis_Homo sapiens_hsa05131 | 1.36872040 |
23 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.36366380 |
24 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.36207763 |
25 | Thyroid cancer_Homo sapiens_hsa05216 | 1.36195019 |
26 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.35770978 |
27 | Platelet activation_Homo sapiens_hsa04611 | 1.33602813 |
28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.28867093 |
29 | Lysosome_Homo sapiens_hsa04142 | 1.28008777 |
30 | Amoebiasis_Homo sapiens_hsa05146 | 1.27870629 |
31 | Legionellosis_Homo sapiens_hsa05134 | 1.27236354 |
32 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.26022163 |
33 | Malaria_Homo sapiens_hsa05144 | 1.25651577 |
34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24785910 |
35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.24196041 |
36 | Tuberculosis_Homo sapiens_hsa05152 | 1.23124621 |
37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.23030173 |
38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.21749255 |
39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21412552 |
40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19965377 |
41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19581056 |
42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19044175 |
43 | Pertussis_Homo sapiens_hsa05133 | 1.17401048 |
44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15488635 |
45 | Salmonella infection_Homo sapiens_hsa05132 | 1.13364505 |
46 | Influenza A_Homo sapiens_hsa05164 | 1.10665682 |
47 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.09130725 |
48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.08773563 |
49 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.08572699 |
50 | Adherens junction_Homo sapiens_hsa04520 | 1.04940304 |
51 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.04818985 |
52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.04616769 |
53 | Prion diseases_Homo sapiens_hsa05020 | 1.03712517 |
54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01004897 |
55 | Hepatitis B_Homo sapiens_hsa05161 | 1.00826434 |
56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.00681929 |
57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.99889266 |
58 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.99304498 |
59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.99156045 |
60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98849584 |
61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.95531999 |
62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94728071 |
63 | Lysine degradation_Homo sapiens_hsa00310 | 0.94157983 |
64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93719277 |
65 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.92065801 |
66 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89354440 |
67 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.88948505 |
68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87017029 |
69 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.86762652 |
70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.86648102 |
71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.85986347 |
72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.85445680 |
73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.85214047 |
74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.84770150 |
75 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84752631 |
76 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84483460 |
77 | Glioma_Homo sapiens_hsa05214 | 0.84234141 |
78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.83176931 |
79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83076438 |
80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81832621 |
81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81814690 |
82 | Prostate cancer_Homo sapiens_hsa05215 | 0.80021912 |
83 | Hepatitis C_Homo sapiens_hsa05160 | 0.79738331 |
84 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.79311831 |
85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79199932 |
86 | Bladder cancer_Homo sapiens_hsa05219 | 0.78808571 |
87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77847584 |
88 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.77660832 |
89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76389266 |
90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.76306415 |
91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71533748 |
92 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71189800 |
93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.69649857 |
94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69216621 |
95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68794034 |
96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67930619 |
97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64504737 |
98 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62056775 |
99 | Endocytosis_Homo sapiens_hsa04144 | 0.61987195 |
100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61072006 |
101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61029339 |
102 | Carbon metabolism_Homo sapiens_hsa01200 | 0.60800210 |
103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.59791254 |
104 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.59718173 |
105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59121634 |
106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58876711 |
107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58644447 |
108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57123699 |
109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56628797 |
110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56543166 |
111 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55561919 |
112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54600851 |
113 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54353219 |
114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53382769 |
115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49459650 |
116 | Phagosome_Homo sapiens_hsa04145 | 0.49407387 |
117 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48780486 |
118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46947711 |